Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain

Journal of Clinical Pharmacology

Volumn 38, Issue 1, 1998, Pages 74-81

  Babul, Najib ^a,d   Provencher, Louise ^b   Laberge, Francis ^b   Harsanyi, Zoltan ^a   Moulin, Dwight ^c  

^a Purdue Frederick ^*  (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Purdue Frederick   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE SULFATE;

ADULT; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SEDATION; SUPPOSITORY; TABLET;

EID: 0031886455     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04380.x     Document Type: Article

References (36)

1. World Health Organization: Cancer Pain Relief, with a Guide to Opioid Availability. Second edition. Geneva: World Health Organization, 1996.
2. Levy MH: Pharmacologic treatment of cancer pain. New Engl J Med 1996;335:1124-1132.
3. Hays H, Hagen N, Thirlwell M, Dhaliwal H, Babul N, Harsanyi Z, Darke AC: Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer 1994;74:1808-1816.
4. Jacox A, Carr DB, Payne R: New clinical practice guidelines for the management of pain in patients with cancer. New Engl J Med 1994;330:651-655.
5. Expert Advisory Committee on the Management of Chronic Severe Pain in Cancer Patients: Cancer Pain: A Monograph on the Management of Cancer Pain. Cat. No. H42-2/5-1984E. Ottawa, Canada: Department of National Health and Welfare, 1984.
6. Weissman DE, Burchman SL, Dinndorf PA, Dahl JL: Handbook of Cancer Pain Management. Second edition. Madison, WI: Wisconsin Pain Initiative, 1990.
7. Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, MacDonald N: Use of the subcutaneous route for administration of narcotics in patients with cancer pain. Cancer 1988;62:407-411.
8. Storey P, Hill HH, St. Louis RH, Traver EE: Subcutaneous infusions for control of cancer symptoms. J Pain Symptom Manage 1990;5:33-41.
9. Warren DE: Practical use of rectal medications in palliative care. J Pain Symptom Manage 1996;11:378-387.
10. Cole L, Hanning CD: Review of the rectal use of opioids. J Pain Symptom Manage 1990;5:118-126.
11. McQuay HJ: The logic of alternative routes (editorial). J Pain Symptom Manage 1990;5:75-76.
12. Ferrante FM, Bedder M, Caplan RA, Chang H-M, Connis RT, Harrison P, et al: Practice guidelines for cancer pain management. Anesthesiology 1996;84:1243-1257.
13. Babul N, Darke AC, Anslow JA, Krishnamurthy TN: Pharmacokinetics of two novel rectal controlled release morphine formulations. J Pain Symptom Manage 1992;7:400-405.
14. Bruera E, Fainsinger R, Spachynski K, Babul N, Harsanyi Z, Darke A: Steady-state pharmacokinetic evaluation of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain. J Clin Pharmacol 1995;35:666-672.
15. Moulin D, Provencher L, Laberge F, Babul N, Harsanyi Z, Darke A: Comparative pharmacokinetics: clinical efficacy and safety of controlled release morphine suppositories and tablets in cancer pain (abstract). In, Proceedings of the American Pain Society 13th Annual Scientific Meeting, November 10-13, 1994, Miami, Florida. Glenview, IL: American Pain Society, 1994.
16. Bruera E, MacMillan K, Hanson J, MacDonald RN: The Edmonton staging system for cancer pain: preliminary report. Pain 1989;37:203-209.
17. Melzack R: The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
18. Goughnour BR, Akinstall WW, Stewart JH: Analgesic response to single and multiple doses of controlled-release morphine tablets and solution in cancer patients. Cancer 1989;63:2294-2297.
19. Thirlwell PM, Sloan PA, Maroun JA, Boos GJ, Besner J-G, Stewart JH, Mount BM: Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer pain. Cancer 1989;63:2275-2283.
20. De Conno F, Ripamonti C, Santa L, Ventafridda V, MacEachern T, Hanson J, Bruera E: Rectal versus oral morphine for the management of cancer pain: a double-blind, double dummy, crossover trial. In, Proceedings of the 7th World Congress on Pain, August 22-27, 1993, Paris, France.
21. Hagen NA, Babul N: Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 1997;79:1428-37.
22. Westerling D, Lindahl S, Anderson K-E, Andersson A: Absorption and bioavailability of rectally administered morphine in women. Eur J Clin Pharmacol 1982;23:59-64.
23. Pannuti F, Rossi AP, Iafelice G, Marraro D, Camera P, Cricca A, et al: Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route: clinical report and preliminary results on morphine pharmacokinetics. Pharmacol Res Commun 1982;14:369-381.
24. Babul N, Darke AC: Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity. Clin Pharmacol Ther 1993;54:286-292.
25. Jonsson T, Christensen CB, Jordening H, Fralund C: The bioavailability of rectally administered morphine. Pharmacol Toxicol 1988;62:203-205.
26. Lindahl S, Olsson AK, Thomson D: Rectal premedication in children. Anesthesia 1981;36:376-379.
27. Ellison NM, Lewis GO: Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository. Clin Pharm 1984;3:614-617.
28. Brook-Williams P, Hoover LH: Morphine suppositories for intractable pain (letter). Can Med Assoc J 1982;126:14.
29. Højted J, Rubeck-Petersen K, Rask H, Bigler D, Broenchristensen C: Comparative bioavailability of a morphine suppository given rectally and in a colostomy. Eur J Clin Pharmacol 1990;39:49-50.
30. Brumley RD: Home made rectal morphine sulfate suppositories. Hospice J 1988;4:95-100.
31. Morgan DJ, McCormick Y, Cosolo W, Roller L, Zalcberg J: Prolonged release of morphine alkaloid from a lipohilic suppository base in vitro and in vivo. Int J Clin Pharmacol Toxicol 1992;30:576-581.
32. Westerling D, Andersson KE: Rectal administration of morphine hydrogel: absorption and bioavailability in women. Acta Anaesthesiol Scand 1985;29:653-656.
33. Maloney CM, Kesner RK, Klein G, Bockenstette J: The rectal administration of MS Contin: clinical implications of use in end stage cancer. Am J Hospice Care 1989;6:34-35.
34. Kaiko RF, Fitzmartin RD, Thomas GB, Goldenheim PD: The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate release 30-mg rectal suppositories and controlled-release 30-mg oral tablets. Pharmacotherapy 1992;12:107-113.
35. Cundiff D, McCarthy K, Savarese JJ, Kaiko R, Thomas G, Grandy R, et al: Evaluation of a cancer pain model for the testing of long-acting analgesics (letter). Cancer 1989;63:2355-2359.
36. Portenoy RK, Coyle N: Controversies in the long-term management of analgesic therapy with advanced cancer. J Pain Symptom Manage 1990;5:307-319.